The Clinical Features of Inflammatory Bowel Disease in Patients with Obesity

Figure 1

Cumulative probabilities of medication use and bowel resection in Crohn’s disease patients with obesity and matched controls: (a) corticosteroids, (b) thiopurines, (c) anti-tumor necrosis factor (anti-TNF) agents, and (d) bowel resection.

(a)

(b)

(c)

(d)